Pharmafile Logo
Pharmafocus logo
Advanced Search

Kisplyx

Showing 2 posts of 2 posts found.

eisa0008_web

Scottish Medicines Consortium recommends Eisai’s Kisplyx for advanced kidney cancer

November 12, 2019
Manufacturing and Production, Sales and Marketing Eisai, Kisplyx, NHS, Sotland, pharma

Eisai’s Kisplyx (lenvatinib) has secured recommendation from the Scottish Medicines Consortium, it has been revealed, meaning that patients on the …

News
eisa0001

EU approval for Eisai kidney cancer treatment

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, Eisai, Kisplyx, Lenvima, everolimus

The European Commission has approved the use of Eisai’s Kisplyx (lenvatinib) for the treatment of renal cell carcinoma (RCC) following …

News
The Gateway to Local Adoption Series

Latest content

Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison

October 23, 2026

Bramacare opens supported-living facility for eating disorder recovery

October 23, 2026

Aiforia deal to expand access to pathology AI

October 22, 2026

SMC accepts atogepant for acute migraine treatment in Scotland

October 22, 2026

New CCO Ogburn joins Cori Clinical

October 21, 2026